logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Hong Kong stocks surge | JD Logistics (02618.HK) rises more than 7%, will officially turn blue on September 8th

date
25/08/2025
According to the Securities Times APP, JD Logistics (02618.HK) rose by over 7%, at the time of publication, it rose by 7.01% to 13.9 Hong Kong dollars, with a turnover of 304 million Hong Kong dollars.
Latest
2 m ago
(002085.SZ) released its performance for the first half of the year, with a net profit attributable to parent company of 5.01 billion yuan, an increase of 25.74%.
2 m ago
Tianfu Communications: Net profit in the first half of the year increased by 37% year-on-year, planning to distribute 5 yuan for every 10 shares.
2 m ago
Director Zheng Zhaie of the National Development and Reform Commission presided over a symposium to listen to opinions and suggestions on expanding domestic demand and stabilizing employment during the "15th Five-Year Plan" period.
2 m ago
Wangchao Wine Co., Ltd. (00828) appoints Caroline Bois Heriard Dubreuil as a non-executive director and vice chairman.
3 m ago
According to Economic Daily News, Donghai Securities released a research report on August 25th, giving a buy rating to JF Biotech (688278.SH). The rating reasons mainly include: 1) the company's performance continues to grow rapidly; 2) Pazopanib continues to increase in volume, deepening the clinical cure of hepatitis B; 3) Long-acting growth hormone has been approved for listing, actively expanding new technology platforms.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.